ANTIMICROBIAL RESISTANCE SOLUTIONS
WITH DR. JOHN H. REX
Latest Newsletters
Latest Government Action





















R&D Insight
Can you help?
Antimicrobial resistance poses a catastrophic threat. If we don’t act now, any one of us could go into hospital in 20 years for minor surgery and die because of an ordinary infection that can’t be treated by antibiotics. And routine operations like hip replacements or organ transplants could be deadly because of the risk of infection.
Dame Sally Davies Tweet
Scary, Scarier, Scariest (Part 2): What can YOU do about it?
FDA analysis of 40-years of antibacterial development: Dheman et al.
NIAID workshop: What is a robust PK-PD package?
Lessons in Discovery from Lynn Silver + Pro-con on alternatives to antibiotics
Novel Biology, Novel Utility, & the Illusion of Skill: What to develop? What to reward?
FDA: Early endpoints and late endpoints suggest a path to global regulatory convergence (Bart et al.)
FDA Workshop: Animal models in support of narrow-spectrum agents for A. baumannii and P. aeruginosa
Public meeting on the LPAD Pathway: Post-meeting thoughts (wonkish)
UK to expand NHS Subscription Pilot! Consultation Period launches
FDA Workshop: Animal Models To Support Antibacterial Development (5 Mar 2020, post-meeting notes)
How hard (and how) to Pull? Net value of Pull via a Transferrable Exclusivity Extension (TEE)
FDA workshop: Insights on inhaled antifungals and antibacterials
The thoughtless person playing with penicillin treatment is morally responsible for the death of the man who succumbs to infection with the penicillin-resistant organism.
Alexander Fleming Tweet
The bipartisan PASTEUR Act is the strongest bill ever written to strengthen antibiotic development and use. It will fix our market failures, expand the pipeline for next generation antibiotics, and save lives. We can’t sit on our hands as this public health crisis arrives – we have to act now.
U.S. Senator Michael Bennet Tweet












